Skip to main content
. 2023 Aug 1;15(15):3912. doi: 10.3390/cancers15153912

Figure 6.

Figure 6

Working hypothesis of piRNA use in diagnosis and therapies. The identification of EV-piRNAs collected by the blood of cancer patients can be useful as diagnostic biomarkers. The engineering of EVs, loading ectopic piRNA, may allow shuttling piRNA useful as new epidrugs.